Literature DB >> 24484908

Curcumin inhibits the increase of labile zinc and the expression of inflammatory cytokines after traumatic spinal cord injury in rats.

Hongbin Ni1, Wei Jin1, Baoyu Yuan1, Tiansheng Zhu1, Jing Wang1, Jian Jiang1, Weibang Liang2, Zhengliang Ma3.   

Abstract

BACKGROUND: The present study aimed to investigate the effects of curcumin on the levels of spinal cord labile zinc (Zn) and inflammatory cytokines in rats after traumatic spinal cord injury (SCI).
METHODS: Adult male Sprague-Dawley rats were subjected to laminectomy at T8-T9 and compression with a vascular clip. There were three groups: (a) sham group; (b) SCI group; and (c) SCI + curcumin group. We measured spinal labile Zn by N-(6-methoxy-8-quinolinyl)-4-methylbenzenesulfonamide (TSQ) fluorescence staining, inflammatory cytokines such as interleukin 1β, interleukin-6, and tumor necrosis factor α by enzyme-linked immunosorbent assay, hindlimb locomotion function by Basso, Beattie, and Bresnahan rating, spinal cord edema by wet dry weight method, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling analysis.
RESULTS: The results showed that SCI caused a significant increase in labile Zn and inflammatory cytokines in the injured rat spinal cord. Treatment with curcumin after SCI markedly downregulated the levels of these agents and ameliorated SCI-induced hindlimb locomotion deficits, spinal cord edema, and apoptosis.
CONCLUSIONS: Curcumin treatment attenuates the increase of labile Zn and the expression of inflammatory cytokines in the injured spinal cord, and this may be a mechanism whereby curcumin improves the outcome after SCI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Curcumin; Inflammatory cytokines; Labile zinc; Spinal cord injury

Mesh:

Substances:

Year:  2014        PMID: 24484908     DOI: 10.1016/j.jss.2013.12.023

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Curcumin as a Promising Neuroprotective Agent for the Treatment of Spinal Cord Injury: A Review of the Literature.

Authors:  Subum Lee; Dae-Chul Cho; Inbo Han; Kyoung-Tae Kim
Journal:  Neurospine       Date:  2022-06-30

Review 2.  "mTOR Signaling Pathway": A Potential Target of Curcumin in the Treatment of Spinal Cord Injury.

Authors:  Jingquan Lin; Xue Huo; Xuehong Liu
Journal:  Biomed Res Int       Date:  2017-06-12       Impact factor: 3.411

3.  Therapeutic efficacy of cyclosporin A against spinal cord injury in rats with hyperglycemia.

Authors:  Zhi-Rong Chen; Yi Ma; Hao-Hui Guo; Zhi-Dong Lu; Qun-Hua Jin
Journal:  Mol Med Rep       Date:  2018-01-11       Impact factor: 2.952

Review 4.  Polyphenols Targeting Oxidative Stress in Spinal Cord Injury: Current Status and Future Vision.

Authors:  Fahadul Islam; Sristy Bepary; Mohamed H Nafady; Md Rezaul Islam; Talha Bin Emran; Sharifa Sultana; Md Amdadul Huq; Saikat Mitra; Hitesh Chopra; Rohit Sharma; Sherouk Hussein Sweilam; Mayeen Uddin Khandaker; Abubakr M Idris
Journal:  Oxid Med Cell Longev       Date:  2022-08-22       Impact factor: 7.310

5.  The Effect of ACTH(4-10) PRO8-GLY9-PRO10 Administration on the Expression of IL-6 and IL-8 in Sprague Dawley Mice with Spinal Cord Injury.

Authors:  Muhammad Azzam; Achmad Fahmi; Budi Utomo; Muhammad Faris; Muhammad Arifin Parenrengi; I Ketut Sudiana; Abdul Hafid Bajamal; Eko Agus Subagio
Journal:  J Neurosci Rural Pract       Date:  2022-06-06

6.  Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase pathway.

Authors:  Hong-Liang Song; Xiang Zhang; Wen-Zhao Wang; Rong-Han Liu; Kai Zhao; Ming-Yuan Liu; Wei-Ming Gong; Bin Ning
Journal:  Neural Regen Res       Date:  2018-01       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.